- A Multi-omics Study of Adenomyosis
- A Prospective Study of Diagnostic Accuracy of Ultrasound
- Adenomyosis and Ulipristal Acetate
- Adenomyosis: Genomic Mechanisms and Biological Response
- Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
- Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis
- Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)
- Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis
- Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis
- Dienogest for Treatment of Adenomyotic Uteri
- Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?
- Effect of Addition of Steroids on Duration of Analgesia
- Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
- Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis
- Electronic Catheter Stethoscope
- Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis
- Health-Related QoL Among Women Receiving Hysterectomy in NTUH
- High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis
- Histopathological Diagnosis of Adenomyosis
- Levonorgestrel Intrauterine System and Adenomyosis
- Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis
- Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri
- LNG-IUS for Treatment of Dysmenorrhea
- Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.
- New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma
- Norwegian Adenomyosis Study I
- Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis
- Norwegian Adenomyosis Study III: Peristalsis
- Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy
- Oxytocin in MRI-HIFU
- Paracervical Block in Laparoscopic Hysterectomy
- Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
- Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis
- Single-port Access Laparoscopic-assisted Vaginal Hysterectomy
- Surgical Success After Laparoscopic vs Abdominal Hysterectomy
- The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
- To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy
- Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)
- Use of Dexamethasone in Uterine Artery Embolization
- Uterine Artery Embolization for Symptomatic Fibroids
- Vaginal Bromocriptine for Treatment of Adenomyosis
- Validation of the Adenomyosis Calculator
- What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography
Clinical Trials
- A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
- Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
- Cabozantinib in Advanced Adrenocortical Carcinoma
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
- Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
- Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
- Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
- Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
- Evaluation of Side Effects of Mitotane
- German Adrenocortical Carcinoma Registry
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
- IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
- International Pediatric Adrenocortical Tumor Registry
- Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
- Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)
- Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
- Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
- Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
- Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
- Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
- Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
- Possible New Therapy for Advanced Cancer
- S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
- Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
- Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
- Structured Evaluation of adRENal Tumors Discovered Incidentally – Prospectively Investigating the Testing Yield
- Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
- Sunitinib in Refractory Adrenocortical Carcinoma
- Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
- Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
- Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
- Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
- Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case Detection
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
- Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
- Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole
- Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
- Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria
- Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.b. Gambiense
- Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
- A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
- A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
- A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases
- A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
- A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
- An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
- Comparison of 2′,3′-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
- Effect of Cenicriviroc on HIV Neurocognitive Impairment
- Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals
- Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder
- Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
- Maraviroc and NeuroAIDS Pathogenesis
- Men Who Have Sex With Men (MSM) Neurocog 1&2 Study
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
- Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
- Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy
- A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
- A Phase II Study in Patients With Alopecia Areata
- A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
- A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
- A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
- A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata
- A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata
- Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
- Aldara for the Treatment of Extensive Alopecia Areata
- Alefacept in Patients With Severe Scalp Alopecia Areata
- Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
- Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
- Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
- Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
- Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss – Alopecia Areata
- Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids
- Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
- Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
- Efficacy and Safety of LH-8 in Paediatric Alopecia Areata
- Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
- Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
- Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata
- Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
- Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.
- Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
- Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
- Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
- Excimer Light for Alopecia Areata
- Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
- Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
- Intralesional Steroids in the Treatment of Alopecia Areata
- Jaktinib Dihydrochloride Monohydrate in Severe Alopecia Areata
- LEO 124249 Ointment in the Treatment of Alopecia Areata
- Modified SALT Score for Alopecia Areata
- Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
- Response of Topical Capsaicin in Alopecia Areata
- Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
- Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
- Stem Cell Educator Therapy in Alopecia Areata
- Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
- The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
- The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata
- The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata
- The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
- Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
- Topical Crisaborole in Patients With Alopecia Areata
- Topical Garlic Concentrate for Alopecia Areata in Children
- Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata
- Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
- TREg Activation in the Treatment of the PELADE (Alopecia Areata)
- Vytorin in the Treatment of Alopecia Areata
- Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
- Alopecia Areata Registry
- ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
- Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
- Efalizumab in the Treatment of Alopecia, Phase II
- Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
- Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
- Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
- Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- Tofacitnib for the Treatment of Alopecia Areata and Variants
- Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- 4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?
- A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.
- A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiMZ Subjects
- A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)
- A Study of DCR-A1AT in Healthy Adult Volunteers and Patients With A1ATD-Associated Liver Disease
- A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency
- AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry
- Alpha-1 Carrier Genomics Study
- Alpha-1 Coded Testing(ACT) Study
- Alpha-1 Foundation DNA and Tissue Bank
- Alpha-1 Foundation Research Registry
- Alpha-1 Research Registry
- Alpha1-antitrypsin Deficiency Registry
- Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
- Aralast alpha1-proteinase Inhibitor Surveillance Study
- ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study
- Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
- Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults
- COPD Exacerbation Blood and Urine Biomarkers Study
- EARCO REGISTRY. History Of Patients With Alpha-1 Antitrypsin
- Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)
- Effects of Different Exercise Training Modalities in Alpha-1 Antitrypsin Deficiency Patients
- Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients
- Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 – Proteinase Inhibitor)
- Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency
- Environment Effect on Six-Minute Walk Test Performance
- Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency
- Evaluate Efficacy and Safety of “Kamada-AAT for Inhalation” in Patients With AATD
- Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype
- Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency
- Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
- GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study
- Long-Term Follow-up Study of ADVM-043
- Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)
- Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency
- Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema
- Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency
- Pharmacokinetic Study of ARALAST (Human Alpha1- PI)
- Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency
- Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation”
- Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency
- Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)
- Respreeza® Self-administration and Learning Program (AmAREtTI Study)
- Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency
- Safety and Pharmacokinetics of Alpha-1 MP in Patients With Alpha1-Antitrypsin Deficiency
- Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
- Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency
- Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home
- Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
- Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels
- Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency
- Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency
- Study of ARO-AAT in Normal Adult Volunteers
- Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
- Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
- Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
- The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency
- The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
- The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency
- A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis
- Biomarker for Mannosidosis Disease (BioMannosidosis)
- Clinical Biomarkers in Alpha-mannosidosis
- Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
- Evaluation of Long-term Efficacy of Treatment With Lamazym
- Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis
- Lamazym Aftercare Study
- Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients
- Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis
- Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
- Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis
- Multi-Center Development of a Novel Diagnostic Test for Alzheimer’s Disease
- Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer’s Disease
- The Chinese Familial Alzheimer’s Network
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer’s Disease
- Alzheimer’s Disease Genetics Study
- Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer’s Disease
- Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
- Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms
- S-Equol in Alzheimer’s Disease 2 Trial
- Study of APH-1105 in Patients With Mild to Moderate Alzheimer’s Disease